NO152904C - Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser. - Google Patents

Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.

Info

Publication number
NO152904C
NO152904C NO820200A NO820200A NO152904C NO 152904 C NO152904 C NO 152904C NO 820200 A NO820200 A NO 820200A NO 820200 A NO820200 A NO 820200A NO 152904 C NO152904 C NO 152904C
Authority
NO
Norway
Prior art keywords
hexapyranose
compounds
preparation
pharmacologically effective
analogy procedure
Prior art date
Application number
NO820200A
Other languages
English (en)
Other versions
NO152904B (no
NO820200L (no
Inventor
Gerhard Bachang
Oskar Wacker
Albert Hartmann
Lajos Tarcsay
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO820200L publication Critical patent/NO820200L/no
Publication of NO152904B publication Critical patent/NO152904B/no
Publication of NO152904C publication Critical patent/NO152904C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO820200A 1981-01-23 1982-01-22 Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser. NO152904C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH43981 1981-01-23

Publications (3)

Publication Number Publication Date
NO820200L NO820200L (no) 1982-07-26
NO152904B NO152904B (no) 1985-09-02
NO152904C true NO152904C (no) 1985-12-11

Family

ID=4187055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820200A NO152904C (no) 1981-01-23 1982-01-22 Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.

Country Status (17)

Country Link
US (1) US4423038A (no)
EP (1) EP0056992A1 (no)
JP (1) JPS57142996A (no)
AU (1) AU7975182A (no)
CA (1) CA1190221A (no)
DD (1) DD202169A5 (no)
DK (1) DK28282A (no)
ES (3) ES508944A0 (no)
FI (1) FI820178L (no)
GB (1) GB2092591B (no)
GR (1) GR78246B (no)
IE (1) IE820137L (no)
IL (1) IL64847A (no)
NO (1) NO152904C (no)
NZ (1) NZ199545A (no)
PT (1) PT74326A (no)
ZA (1) ZA82433B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
ATE23536T1 (de) * 1982-07-23 1986-11-15 Ciba Geigy Ag Neue muramylpeptide und verfahren zu ihrer herstellung.
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
DE3578866D1 (de) * 1984-04-21 1990-08-30 Sandoz Ag 2,3-diamino-2,3-didesoxyhexose-derivate, verfahren zu ihrer herstellung und ihre verwendung.
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DE3572491D1 (en) * 1984-07-25 1989-09-28 Ciba Geigy Ag Phosphatidyl compounds, process for their preparation and their use
EP0174912A3 (de) * 1984-09-13 1986-06-04 Ciba-Geigy Ag Phosphorverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
DE69230372T2 (de) * 1991-03-19 2000-06-15 Cytrx Corp Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität
US6267968B1 (en) 1995-04-07 2001-07-31 Vacsyn S.A. MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
EP0821068A3 (en) * 1996-03-29 1999-06-02 Rohm And Haas Company Novel sphingolipids and a process thereto
JP4087334B2 (ja) * 2001-05-31 2008-05-21 アスビオファーマ株式会社 血小板活性化因子の測定法
FR2933984B1 (fr) * 2008-07-15 2013-01-04 Univ Bourgogne D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
PL2411521T3 (pl) 2009-03-25 2015-08-31 Univ Texas Kompozycje do stymulacji wrodzonej odporności immunologicznej na patogeny u ssaków
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
FR2369292A1 (fr) * 1976-11-02 1978-05-26 Anvar Agents adjuvants immunit
US4153684A (en) * 1976-03-10 1979-05-08 Agence Nationale De Valorisation De La Recherche (Anvar) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
JPS57142996A (en) 1982-09-03
DK28282A (da) 1982-07-24
ES522435A0 (es) 1985-01-01
GR78246B (no) 1984-09-26
NO152904B (no) 1985-09-02
ZA82433B (en) 1982-12-29
IE820137L (en) 1982-07-23
CA1190221A (en) 1985-07-09
NZ199545A (en) 1985-07-12
NO820200L (no) 1982-07-26
AU7975182A (en) 1982-07-29
PT74326A (en) 1982-02-01
ES528142A0 (es) 1986-04-16
GB2092591B (en) 1984-07-04
EP0056992A1 (de) 1982-08-04
US4423038A (en) 1983-12-27
IL64847A0 (en) 1982-03-31
DD202169A5 (de) 1983-08-31
GB2092591A (en) 1982-08-18
ES8406502A1 (es) 1984-07-01
IL64847A (en) 1986-02-28
ES8606370A1 (es) 1986-04-16
ES8502446A1 (es) 1985-01-01
ES508944A0 (es) 1984-07-01
FI820178L (fi) 1982-07-24

Similar Documents

Publication Publication Date Title
NO152904C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.
NO161558C (no) Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner.
NO156828B (no) Analogifremgangsmaate for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
NO833705L (no) Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO164712C (no) Analogifremgangsmaate til fremstilling av metylendifosfonsyre-derivater.
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
NO158752C (no) Fremgangsmaate til fremstilling av etanol.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
NO820959L (no) Fremgangsmaate til fremstilling av acyl-kinolinonderivater
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO823884L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO157329C (no) Analogifremgangsmaate for fremstilling av 5-fluor pgi-forbindelser.
NO823543L (no) Fremgangsmaate til fremstilling av kalsiumsilikat.
NO154636C (no) Fremgangsmaate til fremstilling av krystallinske aminocyklitolderivater.
DK157873C (da) Analogifremgangsmaade til fremstilling af azinorifamycin-forbindelser